Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: A comparative trial of mifepristone-misoprostol versus surgical abortion

被引:120
作者
Winikoff, B
Sivin, I
Coyaji, KJ
Cabezas, E
Xiao, BL
Gu, SJ
Du, MK
Krishna, UR
Eschen, A
Ellertson, C
机构
[1] KEM HOSP,DEPT OBSTET & GYNAECOL,NEW YORK,NY
[2] MINIST SALUD PUBL,JEFE NACL OBSTET & GINECOL,PUNE,MAHARASHTRA,INDIA
[3] NATL RES INST FAMILY PLANNING,BOMBAY,MAHARASHTRA,INDIA
[4] BEIJING MUNICIPAL RES INST FAMILY PLANNING,BEIJING,PEOPLES R CHINA
[5] SHANGHAI MED UNIV,DEPT FAMILY PLANNING,GYNECOL & OBSTET HOSP,SHANGHAI 200032,PEOPLES R CHINA
[6] BHATIA GEN HOSP,HAVANA,CUBA
关键词
mifepristone and misoprostol medical abortion; developing countries; acceptability; safety; efficacy;
D O I
10.1016/S0002-9378(97)70511-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: We investigated safety, efficacy, and acceptability of an oral regimen of medical abortion compared with surgical abortion in three developing countries. STUDY DESIGN: Women (n = 1373) with amenorrhea less than or equal to 56 days chose either surgical abortion (as provided routinely) or 600 mg of mifepristone followed after 48 hours by 400 mu g of misoprostol. This is the appropriate design for studying safety, efficacy, and acceptability among women selecting medical abortion over available surgical services. RESULTS: The medical regimen had more side effects, particularly bleeding, than did surgical abortion but very few serious side effects. Failure rates for medical abortion, although low, exceeded those for surgical abortion: 8.6% versus 0.4% (China), 16.0% versus 4.0% (Cuba), and 5.2% versus 0% (India). Nearly half of failures among medical clients were not true drug failures, however, but surgical interventions not medically necessary (acceptability failures or misdiagnoses). Women were satisfied with either method, but more preferred medical abortion. CONCLUSION: Medical abortion can be safe, efficacious, and acceptable in developing countries.
引用
收藏
页码:431 / 437
页数:7
相关论文
共 13 条
[1]   PROGESTERONE-RECEPTOR BLOCKAGE - EFFECT ON UTERINE CONTRACTILITY AND EARLY-PREGNANCY [J].
BYGDEMAN, M ;
SWAHN, ML .
CONTRACEPTION, 1985, 32 (01) :45-51
[2]  
GAO J, 1988, CONTRACEPTION, V38, P675
[3]   EARLY ABORTION WITH A SINGLE DOSE OF THE ANTIPROGESTIN RU-486 [J].
GRIMES, DA ;
MISHELL, DR ;
SHOUPE, D ;
LACARRA, M .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1988, 158 (06) :1307-1312
[4]  
HE C, 1992, REPROD CONTRACEPTION, V3, P1
[5]  
HERRMANN W, 1982, CR ACAD SCI III-VIE, V294, P933
[6]   TERMINATION OF VERY EARLY-PREGNANCY BY RU-486 - AN ANTIPROGESTATIONAL COMPOUND [J].
KOVACS, L ;
SAS, M ;
RESCH, BA ;
UGOCSAI, G ;
SWAHN, ML ;
BYGDEMAN, M ;
ROWE, PJ .
CONTRACEPTION, 1984, 29 (05) :399-410
[7]   EARLY TERMINATION OF PREGNANCY WITH MIFEPRISTONE (RU-486) AND THE ORALLY ACTIVE PROSTAGLANDIN MISOPROSTOL [J].
PEYRON, R ;
AUBENY, E ;
TARGOSZ, V ;
SILVESTRE, L ;
RENAULT, M ;
ELKIK, F ;
LECLERC, P ;
ULMANN, A ;
BAULIEU, EE .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (21) :1509-1513
[8]   PREGNANCY TERMINATION WITH A HIGH AND MEDIUM DOSAGE REGIMEN OF RU-486 [J].
SHOUPE, D ;
MISHELL, DR ;
BRENNER, PF ;
SPITZ, IM .
CONTRACEPTION, 1986, 33 (05) :455-461
[9]   ORAL-ADMINISTRATION OF RU 486 AND 9-METHYLENE PGE2 FOR TERMINATION OF EARLY-PREGNANCY [J].
SWAHN, ML ;
GOTTLIEB, C ;
GREEN, K ;
BYGDEMAN, M .
CONTRACEPTION, 1990, 41 (05) :461-473
[10]  
*WHO, 1989, HUM REPROD, V4, P718